References
- Lohse M. J., Ukena D., Schwabe U. Demosntration of Ri-type adenosine receptors in bovine myocardium by radioligand binding. Naunyn-Schmiedeberg's Arch. Pharmacol. 1985; 328: 310–316
- Linden J., Patel A., Sadek S. [125I]Aminobenzyladenosine, a new radioligand with improved specific binding to adenosine receptors in the heart. Circ. Res. 1985; 56: 279–284
- Schütz W., Freissmuth M. Adenosine receptors in the heart: controversy about signal transmission. Trends Pharmacol. Sci. 1985; 6: 310–311
- Schütz W., Freissmuth M., Hausleithner V., Tuisl E. Cardiac sarcolemmal purity is essential for the verification of adenylate cyclase inhibition via A1-adenosine receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 1986; 333: 156–162
- Schwabe U., Ukena D., Lohse M. J. Xanthine derivatives as antagonists at A1- and A2-adenosine receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 1985; 330: 212–221
- McPherson G. A. Analysis of radioligand binding experiments on a microcomputing system. Trends Pharmacol. Sci. 1983; 4: 369–370
- Linden J. Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site radioligand and theoretical analysis of mixed stereoisomer radioligand binding. Mol. Pharmacol. 1984; 26: 414–423
- Londos C., Cooper D. M.F., Wolff J. Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. (USA) 1980; 77: 2551–2554
- Goodman R. R., Cooper M. J., Gavish M., Snyder S. H. Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1-receptors in brain membranes. Mol. Pharmacol. 1981; 21: 329–335
- Lohse M. J., Lenschow V., Schwabe U. Two affinity states of Ri-adenosine receptors in brain membranes. Mol. Pharmacol. 1984; 26: 1–9
- Londos C., Wolff J. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. (USA) 1977; 74: 5482–5486
- Daly J. W. Binding of radioactive ligands to adenosine receptors in the central nervous system. Regulatory Function of Adenosine, R. M. Berne, T. W. Rall, R. Rubio. Martinus Nijhoff Publishers, The Hague 1982; 97–112
- Cheng Y., Prusoff W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
- Yamamura H. I., Enna S. J., Kuhar M. J. Neurotrans-mitter Receptor BindingSecond Edition. Raven Press, New York 1985